GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » Short Percentage of Float

Insulet (FRA:GOV) Short Percentage of Float


View and export this data going back to 2007. Start your Free Trial

What is Insulet Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Insulet's Short Percentage of Float

For the Medical Devices subindustry, Insulet's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Insulet's Short Percentage of Float Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Insulet's Short Percentage of Float falls into.


Insulet Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » Short Percentage of Float
Comparable Companies
STE ZBH GMED PEN BIO MASI BRKR DXCM GKOS INSP ABT SYK BSX MDT XTER:SHL SZSE:300760 EW XAMS:PHIA XSWX:SOON SHSE:688271
Traded in Other Exchanges
PODD:USA PODD:Mexico GOV:Germany
Address
100 Nagog Park, Acton, MA, USA, 01720
Website
https://www.insulet.com
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

Insulet Headlines

No Headlines